Nicolas Kint
Show
Sort by
-
CAR plus T-cell lymphoma after cilta-cel therapy for relapsed or refractory myeloma
-
Predicting cytogenetic risk in newly-diagnosed multiple myeloma patients using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI and spinal diffusion-weighted imaging
-
- Journal Article
- A1
- open access
Predicting cytogenetic risk in multiple myeloma using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI, and spinal diffusion-weighted imaging
-
Predicting cytogenetic risk in newly-diagnosed multiple myeloma patients using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI and spinal diffusion-weighted imaging
-
Auto-immune hemolytic anemia and hemophagocytic lymphohistiocytosis as immune-related adverse event in patients with metastatic melanoma and concurrent chronic lymphocytic leukemia : a case series and literature review
-
- Journal Article
- A1
- open access
Selinexor, bortezomib and dexamethasone : an effective salvage regimen for heavily pretreated myeloma patients
-
Immunomodulators in newly diagnosed multiple myeloma : current and future concepts
-
Carfilzomib-induced reticulocytosis in patients with multiple myeloma is caused by impaired terminal erythroid maturation
-
The treatment of multiple myeloma in an era of precision medicine
-
- Journal Article
- A1
- open access
Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes